Kidney Cancer Coverage From Every Angle
Advertisement
Advertisement

Bernard J. Escudier, MD, on RCC: How the IMmotion151 Results Could Improve Treatment

Posted: Monday, June 18, 2018

Bernard J. Escudier, MD, of Gustave Roussy, talks about the best way to use the study’s patient-reported outcomes to improve practice and treatment selection.



By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.